Anvisa Clears Medicine Delivery via iFood & Mercado

What Did Anvisa Actually Decide?

Brazil's health surveillance agency Anvisa revoked previous measures that had banned the sale and advertising of medicines on certain digital platforms. The decision, announced on Monday (10), effectively opens the door for delivery apps such as iFood and marketplaces like Mercado Livre to operate as channels for pharmaceutical products.

Which Platforms Are Affected?

The ruling targets major digital commerce and delivery platforms that had previously been restricted from listing or promoting medicines. Apps like iFood and Mercado Livre are explicitly cited as examples of platforms that will now be able to participate in medicine sales and delivery.

What Does This Mean for Online Shoppers in Brazil?

For consumers, this means greater convenience: prescription and over-the-counter medicines could soon be available through the same apps already used for groceries, restaurant deliveries, and general e-commerce. Pharmacies partnered with these platforms would handle the actual dispensing, while the apps serve as the storefront and logistics layer.

Are There Still Rules to Follow?

While Anvisa has lifted the ban, Brazil's existing pharmaceutical regulations — including requirements around prescription drugs, licensed pharmacies, and advertising standards — remain in force. Platforms and sellers must still comply with all applicable health and commerce laws. Anvisa continues to oversee the sector.

Why Does This Matter for E-Commerce Sellers?

For businesses operating in Brazilian e-commerce, this is a significant market expansion signal. The pharmaceutical segment is one of Brazil's largest retail categories, and access to high-traffic delivery apps could represent a major new sales channel for licensed pharmacies and health product retailers.